CoreHip - Post Market Clinical Follow-Up Study

Status Active, not recruiting

Clinical Trial Summary

The study is designed as a prospective, non-interventional multicentre cohort study. The product under Investigation will be used in Routine clinical practice and according to the authorized Instructions for Use (IfU). Aim of this observational study is to collect clinical and radiological results of the CoreHip® endoprosthesis system in a Standard Patient Population and when used in Routine clinical practice.

Clinical Trial Description

The CoreHip® System has a range of different stem designs to address most of the indications and anatomical conditions met in Primary THA patients within one implant and Instrument System. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT03685110
Study type	Observational
Source	Aesculap AG
Contact
Status	Active, not recruiting
Phase
Start date	October 16, 2018
Completion date	December 2028

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT05302934` - Evaluation of the PHENO4U Data Platform in Patients Undergoing Total Knee Arthroplasty
Active, not recruiting	`NCT03203330` - A Study to Determine the Safety and Efficacy of TG-C in Subjects With Kellgren and Lawrence Grade 2 or 3 OA of the Knee	Phase 3
Not yet recruiting	`NCT05276011` - A Study to Determine the Safety and Efficacy of TG-C in Subjects With Symptomatic Early Hip Osteoarthritis	Phase 2
Recruiting	`NCT05742763` - Platelet-Rich Plasma and the Effects of NSAIDs on Pain and Functional Scores in Knee Osteoarthritis	Phase 1/Phase 2
Completed	`NCT02802085` - VEGA Prospective Kiel
Completed	`NCT01335243` - Efficacy and Safety Study of Lumbar Interbody Fusion With MatriTMBONE Associated With Autologous Bone Marrow	Phase 2
Completed	`NCT02756702` - All Polyethylene Tibia-VEGA Kiel
Not yet recruiting	`NCT02776943` - UCMSC Transplantation in the Treatment of Cartilage Damage	Phase 1/Phase 2
Completed	`NCT01626677` - Follow-Up Study of CARTISTEM® Versus Microfracture for the Treatment of Knee Articular Cartilage Injury or Defect	Phase 3
Completed	`NCT01413061` - Study of Subtalar Arthrodesis Using AlloStem® Versus Autologous Bone Graft	N/A
Completed	`NCT06254976` - Serum Nesfatin-1 and Human Cartilage Glycoprotein-39 Levels in Knee Osteoarthritis	N/A
Recruiting	`NCT05427019` - Continuous Distal Adductor Canal Block With Periarticular Local Anesthetic Infiltration Versus Continuous Distal Adductor Canal Block Alone for Analgesia After Total Knee Arthroplasty	N/A
Completed	`NCT03817632` - Orthopilot Elite Post-Market Clinical Follow-Up
Recruiting	`NCT02687399` - Determine the Efficacy of TT-173. Reducing the the Total Blood Loss Associated With Total Knee Arthroplasty (HESTAT)	Phase 2/Phase 3
Recruiting	`NCT03849885` - Cutibacterium Dermal Colonization: Implications for Total Hip Arthroplasty	Phase 4
Completed	`NCT03442855` - Non-Interventional, Multicenter Bicontact® E PMCF Study
Active, not recruiting	`NCT03291470` - Study to Determine the Efficacy and Safety of TG-C in Subjects With Kellgren/Lawrence Grade 2 or 3 OA of the Knee	Phase 3
Completed	`NCT05291130` - AESCULAP® Plasmafit® Cementless Acetabular System With Vitelene® Vitamin E Stabilized Highly Crosslinked Polyethylene
Active, not recruiting	`NCT04255966` - Plasmafit® Revision Structan® Hip Endoprosthesis Cup